Biomarker Context: When Does MIC B12 Make Clinical Sense
GHK-Cu GHK-Cu is a copper peptide studied for skin health, hair wellness, tissue support and healthy-aging goals
For patients with hepatic impairment, no evidence-based dosing guideline exists

It includes 1-5 intramuscular or subcutaneous injections of 1000 mcg crystalline cyanocobalamin daily, followed by oral doses of 1000-2000 mcg/day Parenteral administration should be reserved for those with significant neurological symptoms NICE guideline: Vitamin B 12 deficiency in over 16s: diagnosis and management: Malabsorption as the confirmed or suspected cause of vitamin B 12 deficiency: Offer replacement to people if: lifelong intramuscular vitamin B12 Autoimmune gastritis is the cause They have had a total gastrectomy They have had a complete terminal ileal resection If the person has a vitamin B 12 deficiency because of malabsorption that is not caused by autoimmune gastritis, or a total gastrectomy or complete terminal ileal resection (for example, malabsorption caused by coeliac disease, partial gastrectomy or some forms of bariatric surgery): Offer vitamin B 12 replacement and Consider intramuscular instead of

The glucagon receptor component is what sets retatrutide dosing apart from all predecessors
A 2024 narrative review synthesizing data across musculoskeletal applications further highlighted BPC-157s potential to promote controlled blood vessel growth and protect neuromuscular connections